Clinical Trials
53 trialsD2C7-IT With Atezolizumab for Recurrent Gliomas
Duke University
Proton Beam or Intensity-Modulated Radiation Therapy in Preserving Brain Function in Patients With IDH Mutant Grade II or III Glioma
NRG Oncology
Concurrent Azeliragon With Craniospinal Irradiation
NYU Langone Health
Carboxylesterase-Expressing Allogeneic Neural Stem Cells and Irinotecan Hydrochloride in Treating Patients With Recurrent High-Grade Gliomas
City of Hope Medical Center
Cognitive Changes of IDH-mutant and IDH-wildtype Glioma Patients After Chemoradiotherapy With Radiation Dose to the Resting State Networks
Washington University School of Medicine
ETAPA I
Duke University
Adaptive Radiotherapy and MRIs Based on Patients With Newly Diagnosed High-Grade Glioma
Columbia University
Trametinib for Pediatric Neuro-oncology Patients With Refractory Tumor and Activation of the MAPK/ERK Pathway.
St. Justine's Hospital
Couples-Based Yoga Program in Improving Quality of Life in Patients With High-Grade Glioma Undergoing Radiation Therapy and Their Partners
M.D. Anderson Cancer Center
A Pilot Study Using 18F-DOPA PET-guided Radiotherapy in Gliomas
Mayo Clinic
A Phase 1b Study of PTC596 in Children With Newly Diagnosed Diffuse Intrinsic Pontine Glioma and High Grade Glioma
Nationwide Children's Hospital
99mTc-1-thio-D-glucose SPECT/CT Versus 18F-Fluoroethyl-l-tyrosine PET/CT in Brain Tumor Imaging
Tomsk National Research Medical Center of the Russian Academy of Sciences
PNOC017
University of California, San Francisco
Trial of Niraparib in Participants With Newly-diagnosed Glioblastoma and Recurrent Glioma
St. Joseph's Hospital and Medical Center, Phoenix
AZD1390 in Recurrent and Newly Diagnosed WHO Grade 4 Glioma Patients
St. Joseph's Hospital and Medical Center, Phoenix
RNA PRIME
University of Florida
m-ctDNA
University Health Network, Toronto
rQNestin
Dana-Farber Cancer Institute
GLIOTARG
Blokhin's Russian Cancer Research Center
Pembrolizumab (MK-3475) in Patients With Recurrent Malignant Glioma With a Hypermutator Phenotype
Memorial Sloan Kettering Cancer Center
Mind-Body Intervention in Glioma Couples
M.D. Anderson Cancer Center
Step Count Monitoring as a Measure of Physical Activity in Patients With Newly Diagnosed Glioma Undergoing Radiation Therapy
M.D. Anderson Cancer Center
Simulation-Based Caregiving Skills Training for Family Members of High Grade Glioma Patients
M.D. Anderson Cancer Center
Niraparib In Recurrent IDH 1/2 Gliomas
Massachusetts General Hospital
Memory-Enriched T Cells in Treating Patients With Recurrent or Refractory Grade III-IV Glioma
City of Hope Medical Center
IMMUNO-IMAGING
Istituto Oncologico Veneto IRCCS
Radiation Therapy With Concomitant and Adjuvant Temozolomide Versus Radiation Therapy With Adjuvant PCV Chemotherapy in Patients With Anaplastic Glioma or Low Grade Glioma
Alliance for Clinical Trials in Oncology
Peds CHAMP1ON
University of Florida
HER2-specific CAR T Cell Locoregional Immunotherapy for HER2-positive Recurrent/Refractory Pediatric CNS Tumors
Seattle Children's Hospital
Accelerating Motor Recovery in Glioma Patients Using Postoperative nrTMS
Beijing Neurosurgical Institute
Proton Radiation Therapy for Gliomas
Massachusetts General Hospital
OLA-TMZ-RTE-01
Centre Francois Baclesse
A Study of 68Ga-PSMA-11 PET Scans in People With Brain Tumors
Memorial Sloan Kettering Cancer Center
rhIL-7-hyFc on Increasing Lymphocyte Counts in Patients With Newly Diagnosed Non-severe Lymphopenic Gliomas Following Radiation and Temozolomide
Washington University School of Medicine
Simultaneous Multinuclear Metabolic MRI in Newly Diagnosed or Recurrent Glioma
Jonsson Comprehensive Cancer Center
Multi-Parametric Quantitative MR Imaging in Evaluation of Brain Tumors
Case Comprehensive Cancer Center
Chimeric Antigen Receptor (CAR) T Cells With a Chlorotoxin Tumor-Targeting Domain for the Treatment of MMP2+ Recurrent or Progressive Glioblastoma
City of Hope Medical Center
M032-HSV-1
University of Alabama at Birmingham
INTERCEPT-H3
German Cancer Research Center
Evaluation of Fluoxetine and Cytotoxic Lysosomal Stress in Glioma (FLIRT)
Duke University
Assessing Brain Metabolism Using MRS With Deuterated Glucose
University of California, San Francisco
ALA-induced PpIX Fluorescence During Brain Tumor Resection
Dartmouth-Hitchcock Medical Center
Genetically Modified T-cells in Treating Patients With Recurrent or Refractory Malignant Glioma
City of Hope Medical Center
C134-HSV-1
University of Alabama at Birmingham
Effect H2 Water on QoL of Patients Receiving Radiotherapy for High Grade Gliomas.
Stony Brook University
PNOC008
University of California, San Francisco
PNOC016
University of California, San Francisco
PRiME
Duke University
FETSMaRT
Sunnybrook Health Sciences Centre
PTCs-based Precision Treatment Strategy on Recurrent High-grade Gliomas
Beijing Tiantan Hospital